Walgreen Co. v. City and County of San Francisco

185 Cal. App. 4th 424, 110 Cal. Rptr. 3d 498, 2010 Cal. App. LEXIS 845
CourtCalifornia Court of Appeal
DecidedJune 8, 2010
DocketA123891
StatusPublished
Cited by55 cases

This text of 185 Cal. App. 4th 424 (Walgreen Co. v. City and County of San Francisco) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walgreen Co. v. City and County of San Francisco, 185 Cal. App. 4th 424, 110 Cal. Rptr. 3d 498, 2010 Cal. App. LEXIS 845 (Cal. Ct. App. 2010).

Opinion

*428 Opinion

McGUINESS, P. J.

In this appeal we consider a challenge to an ordinance enacted by the City and County of San Francisco (the City) banning the sale of tobacco products in certain retail establishments that contain a pharmacy. The ordinance is premised on the notion that a retail store conveys tacit approval of tobacco use when it sells prescription drugs as well as tobacco products. Appellant Walgreen Co. (Walgreens) contends the ordinance violates the equal protection clauses of the federal and state Constitutions, arguing there is no rational basis for prohibiting its stores with pharmacies from selling tobacco products while allowing such sales at “general grocery” stores and “big box” stores that contain pharmacies. Walgreens also claims the ordinance must be invalidated because the City’s Office of Economic Analysis (OEA) abused its discretion by failing to prepare a report on the economic impact of the legislation, a purported violation of voter-enacted Proposition I.

We conclude the OEA’s failure to prepare an economic impact report does not permit an interested party such as Walgreens to invalidate a duly enacted ordinance. The cause of action premised on failure to comply with Proposition I therefore fails as a matter of law. However, we agree with Walgreens that its complaint adequately states a cause of action alleging an equal protection violation. The issue is a close one only because the deferential rational basis test guides our equal protection analysis. Nevertheless, even under that deferential standard, the challenged distinction among stores containing licensed pharmacies is not fairly related to the object of the prohibition on sales of tobacco products. There is no rational basis to believe the supposed implied message conveyed by selling tobacco products at a Walgreens that has a licensed pharmacy in the back of the store is different in any meaningful way from the implied message conveyed by selling such products at a supermarket or big box store that contains a licensed pharmacy. Accordingly, we reverse in part the judgment of the trial court sustaining the City’s demurrer without leave to amend.

Factual and Procedural Background

The legislation challenged in this appeal, City Ordinance No. 194-08 (hereafter the ordinance), amended the San Francisco Health Code to provide that “No person shall sell tobacco products[ 1 ] in a pharmacy, except as provided in [San Francisco Health Code] Section 1009.93.” (S.F. Health Code, § 1009.92.) The term “pharmacy” is defined in the ordinance to refer to *429 the entire retail establishment that includes the portion normally referred to as a pharmacy, giving rise to some confusion in terminology. 2 To avoid confusion and be consistent with the language of the ordinance, we shall refer to the section of a retail establishment in which a licensed pharmacist prepares and sells prescription pharmaceuticals as a “licensed pharmacy,” in contrast to the entire store containing a licensed pharmacy, which the ordinance labels a “pharmacy.” The prohibition on sales of tobacco products is not limited to the licensed pharmacy portion of a store but instead applies to the establishment as a whole.

In addition to traditional independent pharmacies, which sell little more than prescription drugs, over-the-counter medications, and personal care items, the term “pharmacy” encompasses chain stores, supermarkets, and big box stores that sell a variety of products such as food, beverages, paper goods, and miscellaneous items in addition to prescription drugs. However, although a “general grocery store” 3 or a “big box store” 4 that contains a licensed pharmacy qualifies as a “pharmacy” under the ordinance, the ordinance specifically excludes these establishments from the prohibition on sales of tobacco products. (S.F. Health Code, § 1009.93.) As a result, the ordinance prohibits a Walgreens that contains a licensed pharmacy from selling tobacco products but imposes no such limitation on a Safeway supermarket or a Costco big box store that contains a licensed pharmacy.

The legislative findings associated with the ordinance cite the adverse health effects associated with tobacco use. The principal finding upon which the ordinance is premised states: “Through the sale of tobacco products, pharmacies convey tacit approval of the purchase and use of tobacco products. This approval sends a mixed message to consumers who generally patronize pharmacies for health care services . . . .” (S.F. Ord. No. 194-08.) *430 As further support for the ordinance, the City’s Board of Supervisors (board of supervisors or Board) also found that “[p]harmacies and drugstores are among the most accessible and trusted sources of health information among the public . . . ,” and that “[clinicians can have a significant effect on smokers’ probability of quitting smoking . . . .” (Ibid.)

As reflected in the legislative findings, various medical and pharmaceutical organizations advocate prohibiting sales of tobacco products in pharmacies. Among the organizations supporting such a prohibition are California’s Tobacco Education and Research Oversight Committee, the American Pharmacists Association, the California Pharmacists Association, and the California Medical Association. As far back as 1970 the American Pharmaceutical Association declared that “mass display of cigarettes in pharmacies is in direct contradiction to the role of a pharmacy as a public health facility.”

As support for distinguishing between chain drugstores, 5 on the one hand, and general grocery stores and big box stores on the other hand, the ordinance contains a finding that prescription drug sales comprise a much larger part of the business of chain drugstores, as follows: “Prescription drug sales for chain drugstores represent a significantly higher percentage of total sales than for grocery stores and big box stores that contain pharmacies. According to the 2007 Rite Aid[] Annual Report, prescription drug sales represented 63.7% of total sales in fiscal 2007. Walgreen’s 2007 Annual Report documented prescription sales as approximately 65% of net sales that year. Pharmacy sales at Safeway have been estimated at 7.5% of annual volume. Costco’s prescription sales generated 1.5% of total revenue in 2002.”

During public hearings on the ordinance, one of its main proponents, Dr. Mitchell Katz, the City’s director of public health, addressed why the legislation was directed at only certain stores containing licensed pharmacies. Dr. Katz explained: “Well, you know, shouldn’t you include all stores [containing licensed pharmacies]. If you’re going to do this, you know, let’s be fair, look at all stores. But I ask you, in your own experience, if we stop people going into a Walgreens, going into a Rite-Aid, going into one of these independent pharmacies and said, What kind of store are you going into? [T]hey would say, Pharmacy. If you stop someone going into a supermarket, and [say], What kind of store are you going into? [E]ven a supermarket that has a drugstore, they’d say, I’m going into a supermarket.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rodriguez v. City of L.A.
California Court of Appeal, 2025
Gutlin v. U.S. Bank, National Assn. CA2/1
California Court of Appeal, 2025
Licea v. Brown Sugar CA2/1
California Court of Appeal, 2023
Wu v. Public Employment Relations Bd.
California Court of Appeal, 2023
Wu v. Public Employment Relations Board CA3
California Court of Appeal, 2022
Doe v. Finke
California Court of Appeal, 2022
Miller v. Novotney CA2/1
California Court of Appeal, 2022
Inland Oversight Comm. v. City of San Bernardino
238 Cal. Rptr. 3d 455 (California Court of Appeals, 5th District, 2018)
Wiese v. Becerra
306 F. Supp. 3d 1190 (E.D. California, 2018)
W.S. v. S.T.
California Court of Appeal, 2018
W.S. v. S.T.
228 Cal. Rptr. 3d 756 (California Court of Appeals, 5th District, 2018)
Ramirez v. Tulare County District Attorney's Office
9 Cal. App. 5th 911 (California Court of Appeal, 2017)
De Vries v. Regents of UC
California Court of Appeal, 2016
De Vries v. Regents of the University of California
6 Cal. App. 5th 574 (California Court of Appeal, 2016)
Salinas v. Bank of New York Mellon CA4/2
California Court of Appeal, 2016

Cite This Page — Counsel Stack

Bluebook (online)
185 Cal. App. 4th 424, 110 Cal. Rptr. 3d 498, 2010 Cal. App. LEXIS 845, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walgreen-co-v-city-and-county-of-san-francisco-calctapp-2010.